SESSION TITLE: Pulmonary Vascular Disease
SESSION TYPE: Case Report Poster
PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM
INTRODUCTION: Rivaroxaban is a factor Xa inhibitor; commonly being used for treatment of venous thromboembolism (VTE) as one of the newer agents. We report a case of DVT and PE while on therapy with Rivaroxaban; suspected to be secondary to a drug interaction.